ClinicalTrials.gov
public full text
Public Domain
Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients
Multicenter double-blind placebo-controlled parallel-group randomized clinical trial of efficacy and safety of Raphamin in the treatment of coronavirus disease 2019 in outpatients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019)#175006
- Current Pharmacological Practices in Severe COVID-19#878495
- A Novel Coronavirus from Patients with Pneumonia in China, 2019#6811
- Prognosis and Course of COVID-19 Infection in Hospitalised Patients#910829
- Efficacy and Safety of JT001 (VV116) Compared With Paxlovid#844583
Record · ID 871555
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive